CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
5.8576
3.14%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.2848
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 6.0476
Open 6.1676
1-Year Change 1185.18%
Day's Range 5.8476 - 6.1676
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 17, 2024 6.0476 0.3500 6.14% 5.6976 6.2976 5.6376
Sep 16, 2024 5.7376 0.5200 9.97% 5.2176 5.8376 5.1976
Sep 13, 2024 5.3376 0.4400 8.98% 4.8976 5.3376 4.8976
Sep 12, 2024 4.9276 0.0300 0.61% 4.8976 4.9976 4.8876
Sep 11, 2024 4.9176 -0.1100 -2.19% 5.0276 5.0676 4.7976
Sep 10, 2024 4.8286 0.0600 1.26% 4.7686 5.0486 4.7286
Sep 9, 2024 4.7886 -0.0800 -1.64% 4.8686 4.8686 4.6686
Sep 6, 2024 4.7986 -0.2800 -5.51% 5.0786 5.0886 4.7586
Sep 5, 2024 4.9586 -0.0700 -1.39% 5.0286 5.1186 4.9186
Sep 4, 2024 5.0486 0.1100 2.23% 4.9386 5.1986 4.7586
Sep 3, 2024 5.1886 -0.2300 -4.24% 5.4186 5.5786 5.1786
Aug 30, 2024 5.2886 -0.1400 -2.58% 5.4286 5.6586 5.0986
Aug 29, 2024 5.3486 -0.1200 -2.19% 5.4686 5.6986 5.2986
Aug 28, 2024 5.6186 -0.4400 -7.26% 6.0586 6.0586 5.4986
Aug 27, 2024 5.9186 -0.3000 -4.82% 6.2186 6.3386 5.9186
Aug 26, 2024 6.1086 0.0700 1.16% 6.0386 6.3786 5.8286
Aug 23, 2024 6.0086 -0.1800 -2.91% 6.1886 6.2886 5.7486
Aug 22, 2024 5.7486 -0.6700 -10.44% 6.4186 8.2186 5.7486
Aug 21, 2024 5.9286 1.5300 34.78% 4.3986 6.3486 4.3286
Aug 20, 2024 4.2986 0.1000 2.38% 4.1986 4.3186 4.1986

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Curis, Inc. Company profile

About Curis, Inc.

Curis, Inc. is a biotechnology company focused on the development of therapeutics for the treatment of cancer. The Company’s drug candidates include CA-4948 and CI-8993. CA-4948 is an orally available small-molecule inhibitor of Interleukin-I receptor-associated kinase 4, which is undergoing testing in a Phase I open-label dose escalating clinical trial in patients with non-Hodgkin lymphomas. It is also conducting a Phase I open-label, single-arm dose escalating trial in patients with acute myeloid leukemia, and myelodysplastic syndromes. CI-8993 is a monoclonal antibody designed to antagonize the V-domain Ig suppressor of the T cell activation signaling pathway. The Company initiated a Phase Ia/Ib trial of CI-8993 in patients with solid tumors. The Company’s products pipeline includes Fimepinostat, CA-170, CA-327, and PD1/TIM3 Program.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Curis, Inc. revenues decreased 2% to $10.6M. Net loss increased 52% to $45.4M. Revenues reflect Other revenue decrease of 100% to $1K. Higher net loss reflects Research & development Expenses B/F increase of 50% to $32M (expense), Other General and administrative, increase of 43% to $8M (expense), General and administrative expenses increase of 75% to $3.4M (expense).

Equity composition

Common Stock $.01 Par, 03/11, 125M auth., 77,397,663 issd., less 1,047,707 shs. in tres. @ $891K. Insiders own 2.72%. IPO 12/92, 3M shs. @ $7 by Montgomery Secs. *8/00, Co.merged with Ontogeny & Reprogenesis & chgd. name from Creative Biomolecules, Inc. FY'03&'04 are RES-Acct. Change. Summ. Qs reflects RES.

Industry: Biotechnology & Medical Research (NEC)

128 Spring Street
4 Maguire Road
LEXINGTON
MASSACHUSETTS 02421
US

News

Bank of Japan Preview

The Bank of Japan will meet on September 20, 2024, with markets anticipating minimal policy changes. However, inflation risks remain, with core CPI at 2.7% and potential for future interest rate hikes.

09:40, 17 September 2024

FOMC Decision Preview

As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.

09:48, 16 September 2024

ECB Preview: cuts expected but the pace is uncertain

Markets expect the ECB to cut rates again in September, but how many more?

12:34, 11 September 2024

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

Introducing Newsquawk: your new in-platform newsfeed

We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.

14:09, 20 August 2024

Jackson Hole Preview: All eyes on Powell and Gold

The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.

15:24, 19 August 2024

All eyes on inflation: US and UK CPI take centre stage

Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.

14:41, 13 August 2024

People also watch

US100

19,447.20 Price
+0.100% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Oil - Crude

69.42 Price
-0.720% 1D Chg, %
Long position overnight fee 0.0447%
Short position overnight fee -0.0666%
Overnight fee time 21:00 (UTC)
Spread 0.040

Gold

2,572.53 Price
+0.120% 1D Chg, %
Long position overnight fee -0.0187%
Short position overnight fee 0.0105%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

59,757.65 Price
-0.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading